Meridien Research- Tampa

Tampa, Florida 33634

0 studies enrolling now · 11 studies all time

What they study most

Cardiovascular Disease, Chronic Kidney Disease (CKD), Contraception, Dyslipidemia, Dyslipidemias, Gout, High Cardiovascular Risk, Irritable Bowel Syndrome Characterized by Constipation, Mild to Moderate Alzheimer's Disease, Obesity, Overweight, Severe Hypertriglyceridemia

Studies at this site

• Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL — Paused
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function — Completed
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment — Completed
• A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment — Stopped early
• Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease — Completed
• A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) — Completed
• Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed
• Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia — Stopped early
• The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects — Completed